Glucokinase gene mutation screening in argentinean clinically characterized MODY patients

Experimental and Clinical Endocrinology and Diabetes

Volumn 117, Issue 8, 2009, Pages 391-394

  Lopez, A P ^a   Foscaldi, S A ^a   Perez M S ^a   Krochik, G ^b   Rodriguez M ^c   Traversa, M ^a   Puchulu, F M ^a   Hirschler, V ^d   Bergada, I ^e   Frechtel, G D ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^c UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

^d HOSPITAL DURAND   (Argentina)

^e Department of Hematology/Oncology   (Argentina)

Author keywords

Diabetes; Glucokinase; MODY 2; Mutation

Indexed keywords

GLUCOKINASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; ELECTROPHORESIS; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MATURITY ONSET DIABETES MELLITUS; METHODOLOGY; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; SCREENING; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; ARGENTINA; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DNA MUTATIONAL ANALYSIS; GENETIC TESTING; GLUCOKINASE; HUMANS; MUTATION; PEDIGREE; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 70350462953     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0029-1214427     Document Type: Article

References (30)

1. Barrio R, Bellanné-Chantelot C, Moreno JC, et al. Nine novel mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families. J Clin Endocrinol Metab 2002 87 (6) 2532-2539
2. Beards F, Frayling T, Bulman M, et al. Mutations in hepatocyte nuclear factor 4 are not a common cause of maturity-onset diabetes of the young in the UK. Diabetes 1998 47 1152-1154
3. Chankiewitz E, Peschke D, Herberg L, et al. Did the gradual loss of GLUT2 cause a shift to diabetic disorders in the New Zealand obese mouse (NZO/Hl)? Exp Clin Endocrinol Diabetes; 05 2006 114 (5) 262-269
4. Ch̀vre JC, Hani EH, Boutin P, et al. Mutation screening in 18 Caucasian families suggest the existence of other MODY genes. Diabetologia 1998 41 (9) 1017-1023
5. Dimitriadis G, Boutati E, Raptis SA. The importance of adipose tissue in diabetes pathophysiology and treatment. Horm Metab Res 2007 39 (10) 705-706
6. Doria A, Plengvidhya N. Recent advances in the genetics of maturity onset diabetes in the young and other forms of autosomal dominant diabetes. Curr Opinion Endocrinol Diabetes 2000 7 203-210
7. Ellard S, Beards F, Allen LI, et al. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia 2000 43 (2) 250-253
8. Ellard S, Bellanné-Chantelot C, Hattersley AT. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. European Molecular Genetics Quality Network (EMQN) MODY group. Diabetologia 2008 51 546-553
9. Fajans SS, Bell GI, Polonsky KS. Molecular mechanism and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001 345 971-980
10. Frechtel GD, López AP, Rodríguez M, et al. A novel mutation in Exon 5 of the Glucokinase gene in an Argentine MODY Family. Molecular Diagnosis 2003 7 (2) 129-131
11. Froguel P, Vaxillaire M, Sun F, et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 1992 356 (6365) 162-164
12. Froguel P, Zouali H, Vionnet N, et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 1993 328 697-702
13. García-Herrero CM, Galán M, Vincent O, et al. Functional analysis of human glucokinase gene mutations causing MODY 2: exploring the regulatory mechanisms of glucokinase activity. Diabetología 2007 50 (2) 325-333
14. Haines L MSC, Kay Chong Wan DPHIL, Lynn R, et al. Rising incidence of type 2 diabetes in children in the UK. Diabetes Care 2007 30 1097-1101
15. Hara M, Shen J, Pugh W, et al. Sustained expression of hepatocyte nuclear factor-6 leads to loss of pancreatic beta-cells by apoptosis. Exp Clin Endocrinol Diabetes 2007 115 (10) 654-661
16. Hummel M, Vasseur F, Mathieu C, et al. Two Caucasian families with the hepatocyte nuclear factor-1Alpha mutation Tyr218Cys. Exp Clin Endocrinol Diabetes 2007 115 (1) 62-64
17. Lindner TH, Cockburn BN, Bell GI. Molecular Genetics of MODY in Germany. Diabetologia 1999 42 121-123
18. Mahalingam B, Cuesta Muñoz A, Davis EA, et al. Structural model of human glucokinase in complex with glucose and ATP. Diabetes 1999 48 1698-1999
19. Mantovani V, Salardi S, Cerreta V, et al. Identification of eight novel glucokinase mutations in Italian children with maturity-onset diabetes of the young. Hum Mutat 2003 22 (4) 338
20. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997 20 1 [10]
21. Rosenbloom AL. Emerging epidemic of type 2 diabetes in Mexican-American youth. Diabetes Care 1999 22 345-354
22. Stoffel M, Froguel PH, Takeda J, et al. Human glucokinase gene: Isolation, characterization and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Proc Natl Acad Sci USA Genetics 1992 89 7698-7702
23. Tanizawa Y, Matsutani A, Chiu KC, et al. Human glucokinase gene: isolation, structural characterization and identification of a microsatellite repeat polymorphism. Mol Endocrinol 1992 6 1070-1081
24. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Committee report. Diabetes Care 2000 23 (Suppl. 1) [11]
25. Thomson KL, Gloyn AL, Colclough K, et al. Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucassians with Maturity Onset Diabetes of the Young (MODY). Hum Mutat Nov 2003 22 (5) 417
26. Tsakiris D, Ioannou K. An underdiagnosed type of diabetes: The MODY syndromes. Pathophysiology, clinical presentation and renal disease progression. J Nephrol 2004 7 637-641
27. Velho G, Petersen KF, Perseghin G, et al. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest 1996 98 (8) 1755-1761
28. Velho G, Blanche H, Vaxillaire M, et al. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY 2 families. Diabetologia 1997 40 217-224
29. Velho G, Froguel P. Genetic, metabolic and clinical characteristics of maturity onset diabetes of the young. Eur J Endocrinol 1998 138 233-239
30. Winckler W, Weedon MN, Graham RR, et al. Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes. Diabetes 2007 56 (3) 685-693